Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jean‐Philippe Drolet
Observed name:
Jean-Philippe Drolet
Institutions:
Centre hospitalier universitaire de Québec,
Université Laval
Observed institutions:
Montreal Children's Hospital,
McGill University Health Centre,
Centre hospitalier universitaire de Québec,
Centre hospitalier de l'Université Laval,
Université Laval,
Centre de recherche du CHU de Québec-Université Laval,
CHU de Québec-Université Laval,
McGill University
show all 8
ORCID:
0000-0002-8483-4170
Observed ORCID:
0000-0002-8483-4170
OpenAlex ID:
A5085777983
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
2021
·
Matthieu Picard
, Jean-Philippe Drolet
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
59
PDF
Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults
2023
·
Frédéric Brillant-Marquis
, Émilie Proulx
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
16
Rate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance In Quebec, Canada
2018
·
Joseline G. Zafack
, Eveline Toth
, et al.
·
The Pediatric Infectious Disease Journal
·
16
Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice Guidelines
2016
·
Joseline G. Zafack
, Gaston De Serres
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
15
Thalidomide in Refractory Tuberculomas and Pseudoabscesses
2016
·
Isabelle Viel-Thériault
, Roseline Thibeault
, et al.
·
The Pediatric Infectious Disease Journal
·
11
Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study
2024
·
Tiffany Fitzpatrick
, Peter Yamoah
, et al.
·
Vaccine
·
8
Multicentric castleman disease in a child with primary immunodeficiency: Pediatric MCD and Immunodeficiency
2010
·
Jean-Philippe Drolet
, Marie-Astrid Lefebvre
, et al.
·
Pediatric Blood & Cancer
·
5
Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study
2026
·
Michael Smolinski
, Jo Lin Chew
, et al.
·
Human Vaccines & Immunotherapeutics
·
2
PDF
Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study
2023
·
Marie‐Lee Simard
, Natalija Novak
, et al.
·
Clinical & Experimental Allergy
·
1
PDF
Reply to “Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines”
2022
·
Matthieu Picard
, Jean-Philippe Drolet
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
1
PDF
Expression of Semaphorin4C by Th2-stimulated B cells
2010
·
Jean-Philippe Drolet
, Julie Guay
, et al.
·
Allergy Asthma and Clinical Immunology
·
1
PDF
Safety Of Direct Drug Provocation For The Evaluation Of Penicillin Allergy In Low-risk Adults
2024
·
Frederic Brillant-Marquis
, Emilie Proulx
, et al.
·
Journal of Allergy and Clinical Immunology
Characterization of Common Variable Immunodeficiency (CVID) Subgroups through Modulation of Their Interleukin-21 (aCD40/IL-4/IL-21) Pathway in Vitro
2015
·
Marylin Desjardins
, Marianne Beland
, et al.
·
Journal of Allergy and Clinical Immunology
PDF
B-Cells In Allergic Airways Disease: Inhibition Of Epsilon Transcription By Omalizumab
2014
·
Marylin Desjardins
, Jean-Philippe Drolet
, et al.
·
Journal of Allergy and Clinical Immunology
Show more works
View as search
Works count:
14
Citation count:
135
H-index:
6
I10-index:
5
Year
Topic
Type